Scientific Institute IRCCS "E. Medea", Unit for Severe disabilities in developmental age and young adults (Developmental Neurology and Neurorehabilitation), Brindisi, Italy.
Acta Myol. 2022 Dec 31;41(4):188-200. doi: 10.36185/2532-1900-083. eCollection 2022.
Standards of care and new genetic and molecular therapies have contributed to increasing life expectancy of patients with neuromuscular diseases (NMDs). This review presents the clinical evidence for an adequate transition from pediatric to adult care in patients with NMDs considering both physical and psychosocial aspects and attempts at identifying a general pattern of transition in the literature that can be used for all patients with NMDs.
A search was performed on PubMed, Embase and Scopus using generic terms that could be referred to the transition construct specifically related to NMDs. A narrative approach was used to summarise the available literature.
Our review shows that few or no studies explored the transition process from pediatric to adult care in neuromuscular diseases and tried to identify a general pattern of transition applicable to all NMDs.
A transition process taking into consideration physical, psychological, social needs of patient and caregiver could produce positive outcomes. However, there is still no unanimous agreement in the literature on what it consists of and how to achieve an optimal and effective transition.
护理标准和新的基因及分子疗法使神经肌肉疾病(NMD)患者的预期寿命得以延长。本综述从身体和心理社会两方面考虑,为 NMD 患者从儿科向成人护理的顺利过渡提供了临床依据,并尝试在文献中确定一个可用于所有 NMD 患者的一般过渡模式。
在 PubMed、Embase 和 Scopus 中使用可用于特指 NMD 过渡结构的通用术语进行了检索。采用叙述性方法对现有文献进行了总结。
我们的综述表明,很少有或没有研究探讨神经肌肉疾病从儿科到成人护理的过渡过程,并试图确定一个适用于所有 NMD 的一般过渡模式。
考虑到患者和照顾者的身体、心理和社会需求的过渡过程可能会产生积极的结果。然而,文献中对于过渡过程的组成和如何实现最佳和有效的过渡仍没有达成一致意见。